ABSTRACT INFORMATION 

258 ACCEPTED ABSTRACTS 

Each congress, IPIC welcomes the submission of abstracts for original contributions to the field of clinical care of primary immunodeficiencies (PIDs). In 2025, the IPIC Scientific Committee approved record-breaking 258 Abstracts for Poster presentation, and among these, three poster winners. 

These three highest-scored posters will receive an award comprising a certificate and a grant, as well as the opportunity to present their posters in a dedicated congress session. 

Congratulations to the Poster Winners! 

1ST PLACE: Dr Inés Serra for “Analysis of Genetic Overlap Between Inborn Errors of Immunity and Neurodevelopmental Disorders.” 

2ND PLACE: Dr Rohit Rajput for “Machine Learning-Driven Analysis of Epigenetic Signatures in Primary Immunodeficiency Disorders: Investigating Histone Modification Dynamics” 

3RD PLACE: Dr Daniele Canarutto for “Clinical Trial Design and Safety Profile of HDR-Edited CD4 T Cells for the Treatment of Hyper IgM1” 

Abstract information Rifaldy Fajar previous IPIC 2023 poster winner presenting at the congress.
Rifaldy Fajar previous IPIC poster winner presenting at the congress.

Guided Poster Walks 

A selection of the abstracts approved for poster presentation will also be featured during guided poster walks, moderated by specialists in the field. This offers attendees the chance to raise questions and engage in insightful discussions with fellow attendees. 

Each Guided Walk will feature posters from one of the following categories: 

  • Leveraging AI and Disruptive Technologies for Data-Driven Advances in PID Clinical Care

  • Diagnosis and newborn screening advances

  • Autoinflammation, autoimmunity and primary immune regulatory disorders (PIRDs)

  • PID Fundamental research (basic and translational research findings)

  • Life with PID – Insights and quality of life

  • Secondary immunodeficiencies

  • PID management of comorbidities and organ complications, including the liver

  • PID treatment advances (personalized treatments, targeted therapies, gene therapies, novelties in Ig replacement therapy,…)

  • Management of Infections in PID

  • Other topics

Before preparing and submitting your abstract, please read these instructions carefully:

Additional information:

– All accepted abstracts are given the possibility to be presented as posters at IPIC2025.
– The best 3 abstracts will receive an award and the opportunity to present their posters in a dedicated session.
– Only the abstracts with at least one author registered to attend the congress will be included in the congress materials.
– The Scientific Committee will approve abstracts for poster presentation on scientific merit.
– Only posters with at least one author registered to attend the congress will be displayed at IPIC2025.
– Each presenting author can only present one poster.
– Notification or rejection will be sent to the submitting author no later than August 18, 2025.
– Only the submitting author will receive information concerning the abstract.